ÂÜÀòÂÒÂ×

Genghis Lloyd-Harris is currently serving in various roles within the fields of biotechnology, venture capital, and philanthropy. With experience in roles such as Investor-In-Residence at Cancer Research Horizons, Senior Advisor at Lean Life Science, Chairman at ClotProtect, and Senior Advisor at Abingworth, Lloyd-Harris has a strong background in the industry. Additionally, their previous experience at Credit Suisse First Boston and education from Harvard Graduate School of Business Administration, University of Melbourne, and Liverpool University Medical School further solidify their expertise in the field.